CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

News and Events

Latest News

CADTH Recommends Gene Therapy for Infants With Rare Genetic Disorder

March 26, 2021
Onasemnogene abeparvovec (Zolgensma) is the first gene therapy used to treat spinal muscular atrophy — a rare progressive and life-threatening condition that often begins in childhood and is caused by a genetic mutation. Conditions for reimbursement include a price reduction and clinical criteria for initiating treatment. Today, CADTH recom...

New Condition-Level Review Aims to Close Evidence Gaps in Tuberculosis Care

March 24, 2021
More than 35 evidence reviews are mapped to the prevention, identification, treatment, and management of tuberculosis, and accessible on a digital platform With the publication of its first condition-level review, CADTH is giving Canadian policy-makers, clinicians, and patients quick access to evidence on a range of health technologies used to ...

Canada’s First Digital Health Evaluation Network

March 23, 2021
An initiative to advance evaluation in digital health and enhance the healthcare experience Toronto, ON—  The new Canadian Network for Digital Health Evaluation (CNDHE) is an initiative to strengthen Canadian capacity to evaluate digital health interventions. Supported with Health Canada funding, the CNDHE is led by the Centre for Digital ...

Upcoming Events

CADTH Lecture — How to Advance Gender Equity

April 20, 2021
Despite evidence showing that greater gender equity is better for health policy-making and patient care, gender inequity remains a problem in Canadian health care. This lecture will explore the occurrence and consequences of gender inequity in medicine and academia, present why gender equity is important, and provide strategies to promote gender...